Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The relationship between the surgical outcome of vitreous surgery for proliferative diabetic retinopathy and the compliance to ophthalmic follow-up examinations was evaluated.
The medical records of 94 patients that had undergone vitreous surgery for proliferative diabetic retinopathy (PDR) and were followed for at least 6 months were reviewed. The subjects were divided into three groups; the never-treated group consisting of patients who had no previous ophthalmic examination until the first visit when vitreous surgery was prescribed; the non-compliant group consisting of patients with a history of missing ophthalmic examination over a one year period, and the compliant group consisting of patients who had ophthalmic examinations at least once a year. The evaluations included age, gender, plasma level of glycosylated hemoglobin (HbA1c) at the preoperative examination, presence of preoperative panretinal photocoagulation, preoperative best-corrected visual acuity (BCVA), postoperative BCVA at the final examination, status of the PDR, the numbers of vitreous surgeries, and presence of pre- and postoperative neovascular glaucoma.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Never-treated group | The patients who had no previous ophthalmic examination until the first visit when vitreous surgery was prescribed |
| |
| The non-compliant group | The patients with a history of missing ophthalmic examination over a one year period |
| |
| The compliant group | The patients who had ophthalmic examinations at least once a year |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Vitrectomy | Procedure | Vitrectomy. Diabetic retinopathy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Preoperative status | Plasma level of glycosylated hemoglobin (HbA1c) | Preoperative period |
| Preoperative status | Best-corrected visual acuity (BCVA), | Preoperative period |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative status | Postoperative best-corrected visual acuity (BCVA) at 6 months and the final examination | up to 1 year |
| Postoperative status | Status of the proliferative diabetic retinopathy |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The patients that underwent their first vitreous surgery for proliferaftive diabetic retinopathy
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Makoto Inoue, MD | Kyorin Eye Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kyorin Eye Center | Mitaka | Tokyo | 181-8611 | Japan |
Not provided
| ID | Term |
|---|---|
| D010349 | Patient Compliance |
| ID | Term |
|---|---|
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
| ID | Term |
|---|---|
| D014821 | Vitrectomy |
| ID | Term |
|---|---|
| D013508 | Ophthalmologic Surgical Procedures |
| D013514 | Surgical Procedures, Operative |
Not provided
Not provided
Not provided
Not provided
Not provided
| up to 1 year |
| Postoperative status | Presence of neovascular glaucoma. | up to 1 year |